894-41124-74016
2 vaccinations
1 coded response
16 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 750 / TX
- Registered
- 2021-05-04
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-29
Dose 1 — Pfizer-BioNTech
-
2021-05-04
Registered in v-safe
- 2021-05-04
- 2021-05-05
- 2021-05-06
- 2021-05-13
-
2021-05-20
Dose 2 — Pfizer-BioNTech
-
2021-05-21
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Chills, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-05-23
- 2021-05-24
- 2021-05-25
- 2021-05-26
-
2021-05-27
Survey response — day 7, dose 2MedDRA: Rhinorrhoea — Feeling: Poor · Headache, Fatigue or tirednessFree text: Runny noseMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-06-03
- 2021-06-17
- 2021-06-25
- 2021-07-03
- 2021-08-19
- 2021-11-20
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-29 | Pfizer-BioNTech | |
| 2 | 2021-05-20 | Pfizer-BioNTech |
Free text
Release 8 — day 7, dose 2
Systemic reaction (other): Runny nose
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Rhinorrhoea | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release